Cargando…
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
BACKGROUND: The prognosis of lung cancer patients with interstitial lung disease (ILD) is poor, and acute exacerbation (AE) of ILD can occur during chemotherapy as a fatal adverse event. Although AE‐ILD development is correlated with various factors, no reports are investigating the disease activity...
Autores principales: | Sekine, Akimasa, Matama, Goushi, Hagiwara, Eri, Tabata, Erina, Ikeda, Satoshi, Oda, Tsuneyuki, Okuda, Ryo, Kitamura, Hideya, Baba, Tomohisa, Satoh, Hiroaki, Misumi, Toshihiro, Komatsu, Shigeru, Iwasawa, Tae, Ogura, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436679/ https://www.ncbi.nlm.nih.gov/pubmed/35840339 http://dx.doi.org/10.1111/1759-7714.14566 |
Ejemplares similares
-
Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy
por: Okabayashi, Hiroko, et al.
Publicado: (2020) -
Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023) -
Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
por: Okabayashi, Hiroko, et al.
Publicado: (2021) -
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022) -
Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease
por: Muto, Yutaka, et al.
Publicado: (2022)